Jennison Associates
GOSS icon

Jennison Associates’s Gossamer Bio GOSS Stock Holding History

Jennison Associates’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,457,886
Closed -$14.1M – 697
2020
Q4 		$14.1M Sell
1,457,886
-18,757
-1% -$185K 0.01% 376
2020
Q3 		$18.3M Buy
1,476,643
+5,335
+0.4% +$70.7K 0.01% 314
2020
Q2 		$19.1M Buy
1,471,308
+761,875
+107% +$9.58M 0.02% 302
2020
Q1 		$7.2M Buy
709,433
+104,134
+17% +$1.36M 0.01% 369
2019
Q4 		$9.46M Hold
605,299
– – 0.01% 385
2019
Q3 		$10.2M Sell
605,299
-54,310
-8% -$1.08M 0.01% 396
2019
Q2 		$14.6M Sell
659,609
-1,507
-0.2% -$28.8K 0.01% 393
2019
Q1 		$14.3M Buy
+661,116
New +$13.8M 0.01% 404

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Jennison Associates's GOSS Position: Q1 2021 in Review

Jennison Associates sold out of Gossamer Bio (GOSS) in Q1 2021, closing a stake of 1,457,886 shares — an estimated $14.1M sold.

Jennison Associates first reported a position in GOSS in Q1 2019 and held it in 8 quarters. The position peaked at $19.1M in Q2 2020. 123 funds tracked by Wall St. Rank hold GOSS as of Q1 2021.

  • Jennison Associates reported no remaining Gossamer Bio position as of Q1 2021 after selling out during the quarter.
  • Jennison Associates sold 1,457,886 Gossamer Bio shares in Q1 2021, an estimated $14.1M.
  • Jennison Associates first reported a position in Gossamer Bio in Q1 2019 and held it in 8 quarters.
  • Jennison Associates's Gossamer Bio position peaked at $19.1M in Q2 2020.
  • 123 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2021.

Based on Jennison Associates's 13F filing for Q1 2021, filed 11 May 2021.